BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3498419)

  • 1. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease.
    Kaufmann HJ; Taubin HL
    Ann Intern Med; 1987 Oct; 107(4):513-6. PubMed ID: 3498419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.
    Bjarnason I; Zanelli G; Smith T; Prouse P; Williams P; Smethurst P; Delacey G; Gumpel MJ; Levi AJ
    Gastroenterology; 1987 Sep; 93(3):480-9. PubMed ID: 3609658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study.
    Felder JB; Korelitz BI; Rajapakse R; Schwarz S; Horatagis AP; Gleim G
    Am J Gastroenterol; 2000 Aug; 95(8):1949-54. PubMed ID: 10950041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease.
    Bonner GF; Walczak M; Kitchen L; Bayona M
    Am J Gastroenterol; 2000 Aug; 95(8):1946-8. PubMed ID: 10950040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects of non-steroidal antirheumatic agents in the lower intestinal tract].
    Bielecki JW; Filippini L
    Schweiz Med Wochenschr; 1993 Jul; 123(29):1419-28. PubMed ID: 8367700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.
    Teahon K; Bjarnason I
    Gut; 1993 Nov; 34(11):1535-8. PubMed ID: 8244139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prerequisites for therapy of inflammatory bowel diseases. Pathophysiology--symptomatology--diagnosis].
    Haag K; Schölmerich J
    Fortschr Med; 1991 Apr; 109(11):232-7. PubMed ID: 1855748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal pH profiles in patients with inflammatory bowel disease.
    Press AG; Hauptmann IA; Hauptmann L; Fuchs B; Fuchs M; Ewe K; Ramadori G
    Aliment Pharmacol Ther; 1998 Jul; 12(7):673-8. PubMed ID: 9701532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic findings in differential diagnosis of chronic inflammatory bowel diseases (ulcerative colitis, Crohn disease, indeterminate colitis)].
    Otto HF
    Internist (Berl); 1991 Sep; 32(9):511-7. PubMed ID: 1960018
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine.
    Davies NM
    Dis Colon Rectum; 1995 Dec; 38(12):1311-21. PubMed ID: 7497845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
    Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
    J Clin Gastroenterol; 2016 Feb; 50(2):152-6. PubMed ID: 26485106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ileoscopy, colonoscopy, and backwash ileitis in children with inflammatory bowel disease: quid pro quo?
    Newman SL
    J Pediatr Gastroenterol Nutr; 1987; 6(3):325-7. PubMed ID: 3430241
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.
    Kvasnovsky CL; Aujla U; Bjarnason I
    Scand J Gastroenterol; 2015 Mar; 50(3):255-63. PubMed ID: 25314574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.
    Tzivras M; Koussoulas V; Giamarellos-Bourboulis EJ; Tzivras D; Tsaganos T; Koutoukas P; Giamarellou H; Archimandritis A
    World J Gastroenterol; 2006 Jun; 12(21):3416-9. PubMed ID: 16733861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Undefined chronic colitis with its patho-histologic differentiation from Crohn disease and ulcerative colitis].
    von Herbay A; Sinn P; Otto HF
    Z Gastroenterol Verh; 1989 Jul; 24():22-5. PubMed ID: 2474961
    [No Abstract]   [Full Text] [Related]  

  • 19. NSAID-induced small bowel diaphragms and strictures diagnosed with intraoperative enteroscopy.
    Shumaker DA; Bladen K; Katon RM
    Can J Gastroenterol; 2001 Sep; 15(9):619-23. PubMed ID: 11573106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic pseudopolyposis in inflammatory bowel disease.
    Monteserín L; Jiménez M; Molina G; Reyes N; Hernando M; Sierra M; Vaquero L
    Gastroenterol Hepatol; 2017 May; 40(5):375-376. PubMed ID: 28012580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.